These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


401 related items for PubMed ID: 15466085

  • 1. Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants.
    Suresh GK, Clark RE.
    Pediatrics; 2004 Oct; 114(4):917-24. PubMed ID: 15466085
    [Abstract] [Full Text] [Related]

  • 2. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA.
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW, Ortega-Sanchez IR, Scott RD, Rosenstein NE, ABCs Team.
    Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.
    Akker-van Marle ME, Rijnders ME, Dommelen P, Fekkes M, Wouwe JP, Amelink-Verburg MP, Verkerk PH.
    BJOG; 2005 Jun; 112(6):820-6. PubMed ID: 15924544
    [Abstract] [Full Text] [Related]

  • 6. Universal bilirubin screening for severe neonatal hyperbilirubinemia.
    Bhutani VK, Vilms RJ, Hamerman-Johnson L.
    J Perinatol; 2010 Oct; 30 Suppl():S6-15. PubMed ID: 20877410
    [Abstract] [Full Text] [Related]

  • 7. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).
    Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM.
    J Perinatol; 2009 Feb; 29 Suppl 1():S25-45. PubMed ID: 19177057
    [Abstract] [Full Text] [Related]

  • 8. Management of hyperbilirubinemia: quality of evidence and cost.
    Holtzman NA.
    Pediatrics; 2004 Oct; 114(4):1086-8. PubMed ID: 15466110
    [No Abstract] [Full Text] [Related]

  • 9. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB, Rose DN.
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [Abstract] [Full Text] [Related]

  • 10. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.
    Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK.
    Pediatrics; 2008 Jan; 121(1):e170-9. PubMed ID: 18166536
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness and test-performance factors in relation to universal newborn hearing screening.
    Gorga MP, Neely ST.
    Ment Retard Dev Disabil Res Rev; 2003 Jan; 9(2):103-8. PubMed ID: 12784228
    [Abstract] [Full Text] [Related]

  • 13. National Institute of Child Health and Human Development (NICHD) conference on kernicterus: a population perspective on prevention of kernicterus.
    Palmer RH, Keren R, Maisels MJ, Yeargin-Allsopp M.
    J Perinatol; 2004 Nov; 24(11):723-5. PubMed ID: 15175630
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Screening and early postnatal management strategies to prevent hazardous hyperbilirubinemia in newborns of 35 or more weeks of gestation.
    Maisels MJ.
    Semin Fetal Neonatal Med; 2010 Jun; 15(3):129-35. PubMed ID: 20034861
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA, Grobman WA.
    Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
    [Abstract] [Full Text] [Related]

  • 19. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A, Stone GW, Mahoney E, Lavelle TA, Shi C, Berezin RH, Lahue BJ, Clark MA, Lacey MJ, Russell ME, Ellis SG, Hermiller JB, Cox DA, Cohen DJ, TAXUS-IV Investigators.
    J Am Coll Cardiol; 2006 Jul 18; 48(2):253-61. PubMed ID: 16843171
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week.
    Bhutani VK, Johnson LH, Keren R.
    Pediatr Clin North Am; 2004 Aug 18; 51(4):843-61, vii. PubMed ID: 15275978
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.